Personalized Medicine Peer Review Journals
Personalized
drugs is that the craft of medical treatment to the individual characteristics of every patient. The approach depends on scientific breakthroughs in our understanding of however a person’s distinctive molecular and genetic profile makes them liable to bound diseases. This same research is increasing our ability to predict that medical treatments can be safe and effective for every patient, and which of them won't be. Personalized
drugs could also be thought of Associate in
Nursing extension of ancient approaches to understanding and treating malady. Equipped with tools that ar a lot of precise, physicians will choose a medical aid or treatment protocol supported a patient’s molecular profile that will not solely minimize harmful aspect effects and guarantee a a lot of no-hit outcome, but may facilitate contain prices compared with a “trial-and-error” approach to malady treatment. Personalized
drugs has the potential to vary the method we expect about, determine and manage
health issues. it's already having Associate in
Nursing exciting impact on each clinical analysis and patient care, and this impact will grow as our understanding and technologies improve.As the system of stakeholders works to advance personalised drugs, collaboration with government regulators and policymakers is important to encourage widespread use of those new tools and technologies. The regulatory method should evolve in response to advances that ar targeted to smaller patient populations supported genetic profiles, and policies and legislation should be enacted that offer incentives for innovative analysis and adoption of recent technologies. Together, progress within the analysis, clinical care, and policy sanctioning personalised medicine has nice potential to boost the standard of patient care and to assist contain
health care prices.
High Impact List of Articles
-
Binge eating disorder among obese/overweight in Pakistan: Under-diagnosed, undertreated and misunderstood
Madeeha Malik, Waseem Shaukat and Azhar Hussain
Research Article: Clinical Investigation
-
Binge eating disorder among obese/overweight in Pakistan: Under-diagnosed, undertreated and misunderstood
Madeeha Malik, Waseem Shaukat and Azhar Hussain
Research Article: Clinical Investigation
-
Binge eating disorder among obese/overweight in Pakistan: Under-diagnosed, undertreated and misunderstood
Madeeha Malik, Waseem Shaukat and Azhar Hussain
Research Article: Clinical Investigation
-
Binge eating disorder among obese/overweight in Pakistan: Under-diagnosed, undertreated and misunderstood
Madeeha Malik, Waseem Shaukat and Azhar Hussain
Research Article: Clinical Investigation
-
Binge eating disorder among obese/overweight in Pakistan: Under-diagnosed, undertreated and misunderstood
Madeeha Malik, Waseem Shaukat and Azhar Hussain
Research Article: Clinical Investigation
-
Binge eating disorder among obese/overweight in Pakistan: Under-diagnosed, undertreated and misunderstood
Madeeha Malik, Waseem Shaukat and Azhar Hussain
Research Article: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Lung cancer vaccines: a review of three ongoing trials
Sarah R Goodyear, Hossein Borghaei
Review Article: Clinical Investigation
-
Lung cancer vaccines: a review of three ongoing trials
Sarah R Goodyear, Hossein Borghaei
Review Article: Clinical Investigation
-
Lung cancer vaccines: a review of three ongoing trials
Sarah R Goodyear, Hossein Borghaei
Review Article: Clinical Investigation
-
Lung cancer vaccines: a review of three ongoing trials
Sarah R Goodyear, Hossein Borghaei
Review Article: Clinical Investigation
-
Lung cancer vaccines: a review of three ongoing trials
Sarah R Goodyear, Hossein Borghaei
Review Article: Clinical Investigation
-
Lung cancer vaccines: a review of three ongoing trials
Sarah R Goodyear, Hossein Borghaei
Review Article: Clinical Investigation
Relevant Topics in Clinical